$0.225
-0.029 (-12.96%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de VVOS por análisis de gráficos similares
Alphio's VVOS stock price prediction model matches the current Vivos Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (+1.67%). The 1-week path is $0.23 (+1.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Vivos Therapeutics Inc?
Vivos Therapeutics is not a good buy right now due to significant financial instability and declining stock performance. The current price is $0.22, which has dropped 91.11% year-to-date. Additionally, the RSI is at 21.92, indicating the stock is oversold, but this does not guarantee a reversal. The company faces a widening net loss of $5.5 million in Q2 2026, alongside a cash position of only $1.8 million, which raises concerns about its ability to fund operations in the near term. The main risk is the potential for further equity dilution as analysts suggest significant reinforcement of the balance sheet is needed.
VVOS cerró en $0.22 el Friday, tras bajar -12.96%
Vivos Therapeutics Inc (VVOS) last closed at $0.2249, losing -12.96%. These facts feed the 1-day and 1-week VVOS price prediction above.
Factores de la previsión
Los factores de la previsión de Vivos Therapeutics Inc (VVOS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de VVOS, ordenadas por similitud.
Análisis de estacionalidad de VVOS
Historically the probability of a positive August return for VVOS is 28.57%. July offers the highest probability of a positive month at 30.30%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de VVOS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $2.25 | $2.45 | $2.86 | +991.59% |
| Sep 2026 | $2.87 | $2.89 | $3.22 | +1185.87% |
| Oct 2026 | $2.50 | $2.63 | $2.72 | +1067.28% |
| Nov 2026 | $1.79 | $2.11 | $2.53 | +837.94% |
| Dec 2026 | $2.03 | $2.50 | $2.98 | +1011.76% |
En 2026, se proyecta que Vivos Therapeutics Inc (VVOS) oscile entre $1.79 y $3.22.
Previsión mensual de Vivos Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Vivos Therapeutics Inc promedie $2.45, con un mínimo de $2.25 y un máximo de $2.86.
En Sep de 2026, se proyecta que Vivos Therapeutics Inc promedie $2.89, con un mínimo de $2.87 y un máximo de $3.22.
En Oct de 2026, se proyecta que Vivos Therapeutics Inc promedie $2.63, con un mínimo de $2.50 y un máximo de $2.72.
En Nov de 2026, se proyecta que Vivos Therapeutics Inc promedie $2.11, con un mínimo de $1.79 y un máximo de $2.53.
En Dec de 2026, se proyecta que Vivos Therapeutics Inc promedie $2.50, con un mínimo de $2.03 y un máximo de $2.98.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.